AL
Senior Manager/Associate Director, Commercial Operations, Germany
Contract type
Ongoing
Work mode
Hybrid · Munich, Germany
Experience
Senior · 5+ years
Job description
Senior Manager/Associate Director, Commercial Operations supporting the launch of a new rare disease product for Rett syndrome in Germany. The role covers commercial strategy, launch readiness, cross-functional execution and performance tracking in the German market.
At a glance
- Employment
- Full-time · Employee (employment agreement)
- Work mode
- Hybrid · Munich, Germany
- Languages
- English – fluent
- Pay
- EUR 98,000 – 138,400 / year
What you'll do
- Support the development of launch strategy, commercial planning, and business planning for Germany
- Define goals, strategies, tactics, and market analyses to maximize the potential of a new rare disease product for Rett syndrome
- Oversee marketing and launch activities, including brand, marketing, PR, and digital plans; investment alignment; forecasting; demand planning; and launch execution
- Track launch performance and support commercial and field force excellence initiatives
- Coordinate cross-functional alignment across medical, marketing, PR, digital, market access, and reimbursement activities; assess market research and competitive benchmarks; and support the development of commercial materials for KAMs
- Support customer-facing execution, CRM and territory management systems, ROI evaluation, budget allocation, sales targets, and incentive systems
- Partner closely with the EU Commercial team and the GM Germany to ensure strong regional-country alignment on commercial priorities and projects
- Operate in line with ethical standards and company procedures; actively participate in and lead local sales and marketing meetings and cross-functional project groups; and perform other responsibilities as assigned
What we're looking for
- Master's degree in science, healthcare, business, or a relevant field required
- Proven commercial track record in the pharmaceutical industry, with at least 5–7 years of experience in a specialty indication, such as neuroscience
- Broad commercial experience across marketing, PR, digital, sales, and business intelligence
- Growth mindset, collaborative working style, strong team orientation, and successful track record of leading product launches
- Self-drive and serve as a strong collaborator, bridge builder, and executor
- Communicate effectively in English, both written and spoken, across international Acadia teams
- Urgency, ownership, strong organizational discipline, a can-do mindset, and practical problem-solving ability
- Resilience and adaptability in a fast-paced, dynamic market environment
- Operate effectively with ambiguity and create business results in a start-up environment
Nice to have
- Experience in a rare disease care environment is a clear advantage
Your team
Commercial Operations
Benefits
- Competitive base salary
- Discretionary bonus and equity awards based on factors such as individual and organizational performance
- Medical, dental, and vision insurance
- Employer-paid life, disability, business travel and EAP coverage
- 401(k) Plan with a fully vested company match 1:1 up to 5%
- Employee Stock Purchase Plan with a 2-year purchase price lock-in
- 15+ vacation days
- 13-15 paid holidays, including office closure between December 24th and January 1st
- 10 days of paid sick time
- Paid parental leave benefit
- Tuition assistance
Apply
About Acadia Pharmaceuticals
Turning scientific promise into meaningful innovation
Acadia's commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. The company is developing a pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs addressing other underserved patient needs.
Mission
Turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world
Key facts
- Pharmaceuticals
- Commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome
- Pipeline includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis
- Preparing Acadia Pharmaceuticals Germany for the launch of a new rare disease product for Rett syndrome